Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
Price Target
Average
--6.17%
Revenue Forecast
Estimate
19.30%
EBIT
Estimate
47.70%
Net Income
Estimate
79.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exelixis, Inc.
Wall Street analysts predict an average 1-year price target for EXEL of $31.4 , with forecasts ranging from
a
low of
$18 to a high of $42 .
EXEL Lowest Price Target
Wall Street Target
18 USD
-46.27%
EXEL Average Price Target
Wall Street Target
31.4 USD
-6.17%
EXEL Highest Price Target
Wall Street Target
42 USD
25.37%
REVENUE FORECAST
Revenue Forecast Chart EXEL
EBIT FORECAST
EBIT Forecast Chart EXEL
NET INCOME FORECAST
Net Income Chart EXEL